Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4078)
All Articles published online
|
Apr 28, 2008 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hass HG, Nehls O, Jobst J, Frilling A, Vogel U, Kaiser S. Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: Detection by oligonucleotide microarray and real-time PCR analysis. World J Gastroenterol 2008; 14(16): 2501-2510 [PMID: 18442196 DOI: 10.3748/wjg.14.2501] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i16/2501.htm |
| Number | Citing Articles |
| 1 |
Pattaya Seeree, Phorutai Pearngam, Supeecha Kumkate, Tavan Janvilisri. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma. International Journal of Genomics 2015; 2015: 1 doi: 10.1155/2015/179528
|
| 2 |
Dipok Kumar Dhar, Steven W.M. Olde Damink, James Hal Brindley, Andrew Godfrey, Michael H. Chapman, Neomal S. Sandanayake, Fausto Andreola, Sybille Mazurek, Tayyaba Hasan, Massimo Malago, Stephen P. Pereira. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer. Cancer 2013; 119(3): 575 doi: 10.1002/cncr.27611
|
| 3 |
Ming-Huang Chen, Chueh-Chuan Yen, Chi-Tung Cheng, Ren-Chin Wu, Shih-Chiang Huang, Chung-Shan Yu, Yi-Hsiu Chung, Chun-Yu Liu, Peter Mu-Hsin Chang, Yee Chao, Ming-Han Chen, Yu-Fen Chen, Kun-Chun Chiang, Ta-Sen Yeh, Tzu Chi Chen, Chi-Ying F. Huang, Chun-Nan Yeh. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. Oncotarget 2015; 6(27): 23594 doi: 10.18632/oncotarget.4335
|
| 4 |
Chen Li, Weixing Shen, Sheng Shen, Zhilong Ai. Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinoma. Computational Biology and Chemistry 2013; 47: 192 doi: 10.1016/j.compbiolchem.2013.08.010
|
| 5 |
Zhuolun Song, Wei Chen, Dipti Athavale, Xiaodong Ge, Romain Desert, Sukanta Das, Hui Han, Natalia Nieto. Osteopontin Takes Center Stage in Chronic Liver Disease. Hepatology 2021; 73(4): 1594 doi: 10.1002/hep.31582
|
| 6 |
Ratthaphol Kraiklang, Chawalit Pairojkul, Narong Khuntikeo, Kanokwan Imtawil, Sopit Wongkham, Chaisiri Wongkham, Mitchell Ho. A Novel Predictive Equation for Potential Diagnosis of Cholangiocarcinoma. PLoS ONE 2014; 9(2): e89337 doi: 10.1371/journal.pone.0089337
|
| 7 |
Seung-Ok Lee. Physiologic and pathologic experimental models for studying cholangiocytes. The Korean Journal of Hepatology 2008; 14(2): 139 doi: 10.3350/kjhep.2008.14.2.139
|
| 8 |
SONG-TAO XU, CHUN GUO, XIANG DING, WEN-JUAN FAN, FU-HUA ZHANG, WAN-LING XU, YONG-CHAO MA. Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells. Molecular Medicine Reports 2015; 11(5): 3701 doi: 10.3892/mmr.2015.3202
|
| 9 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 10 |
Holger G. Hass, Ulrich Vogel, Michael Scheurlen, Jürgen Jobst. Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays. Gut and Liver 2018; 12(3): 306 doi: 10.5009/gnl17277
|
| 11 |
Xin-Lin Wu, Kai-Jin Lin, Ai-Ping Bai, Wan-Xiang Wang, Xing-Kai Meng, Xiu-Lan Su, Ming-Xing Hou, Pei-De Dong, Jun-Jing Zhang, Zhao-Yang Wang, Lin Shi. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. World Journal of Gastroenterology 2014; 20(30): 10440-10448 doi: 10.3748/wjg.v20.i30.10440
|
| 12 |
Min-A Seol, In-Sun Chu, Mi-Jin Lee, Goung-Ran Yu, Xiang-Dan Cui, Baik-Hwan Cho, Eun-Kyung Ahn, Sun-Hee Leem, In-Hee Kim, Dae-Ghon Kim. Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-78
|
| 13 |
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7
|
| 14 |
Yan Zheng, Chuang Zhou, Xin-Xin Yu, Chao Wu, Hu-Liang Jia, Xiao-Mei Gao, Ji-Meng Yang, Chao-Qun Wang, Qin Luo, Ying Zhu, Yu Zhang, Jin-Wang Wei, Yuan-Yuan Sheng, Qiong-Zhu Dong, Lun-Xiu Qin. Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0226-x
|
| 15 |
Wei Zhong, Lianzhi Dai, Jing Liu, Song Zhou. Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8594
|
| 16 |
Takahiro Yoshizawa, Takeshi Uehara, Mai Iwaya, Tomoyuki Nakajima, Akira Shimizu, Koji Kubota, Tsuyoshi Notake, Noriyuki Kitagawa, Hitoshi Masuo, Hiroki Sakai, Hikaru Hayashi, Hidenori Tomida, Shiori Yamazaki, Shohei Hirano, Hiroyoshi Ota, Yuji Soejima. An Immunohistochemical Analysis of Osteopontin and S100 Calcium-binding Protein P is Useful for Subclassifying Large- and Small-duct Type Intrahepatic Cholangiocarcinomas. American Journal of Surgical Pathology 2024; 48(6): 751 doi: 10.1097/PAS.0000000000002224
|
| 17 |
Motohiro Imano, Takao Satou, Tatsuki Itoh, Yoshifumi Takeyama, Atsushi Yasuda, Ying-Feng Peng, Masayuki Shinkai, Seiji Haji, Chikao Yasuda, Takuya Nakai, Takushi Yasuda, Haruhiko Imamoto, Kiyotaka Okuno, Hitoshi Shiozaki, Harumasa Ohyanagi. An Immunohistochemical Study of Osteopontin in Pigment Gallstone Formation. The American Surgeon™ 2010; 76(1): 91 doi: 10.1177/000313481007600118
|
| 18 |
Somsak Likhitrattanapisal, Jaitip Tipanee, Tavan Janvilisri. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma. Tumor Biology 2016; 37(9): 12755 doi: 10.1007/s13277-016-5186-8
|
| 19 |
Boris R.A. Blechacz, Gregory J. Gores. Molecular Genetics of Liver Neoplasia. 2010; : 75 doi: 10.1007/978-1-4419-6082-5_5
|
| 20 |
Q-X Huang, J-Y Cui, H Ma, X-M Jia, F-L Huang, L-X Jiang. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets. Cancer Gene Therapy 2016; 23(2-3): 48 doi: 10.1038/cgt.2015.66
|
| 21 |
Ming‐Huang Chen, Kun‐Ju Lin, Wu‐Lung R. Yang, Ya‐Wen Kao, Tsung‐Wen Chen, Shu‐Chaou Chao, Peter Mu‐Hsin Chang, Chun‐Yu Liu, Cheng‐Hwai Tzeng, Yee Chao, Ming‐Han Chen, Chun‐Nan Yeh, Chi‐Ying F. Huang. Gene expression‐based chemical genomics identifies heat‐shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Cancer 2013; 119(2): 293 doi: 10.1002/cncr.27743
|
| 22 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 23 |
Marut Laohaviroj, Yaovalux Chamgramol, Chawalit Pairojkul, Jason Mulvenna, Banchob Sripa. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases. Asian Pacific Journal of Cancer Prevention 2016; 17(1): 201 doi: 10.7314/APJCP.2016.17.1.201
|
| 24 |
Akihito Tsubota, Kenji Matsumoto, Kaoru Mogushi, Koichi Nariai, Yoshihisa Namiki, Sadayori Hoshina, Hiroshi Hano, Hiroshi Tanaka, Hirohisa Saito, Norio Tada. IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress. Carcinogenesis 2010; 31(3): 504 doi: 10.1093/carcin/bgp313
|
| 25 |
Kanlayanee Sawanyawisuth, Nattawat Tantapotinan, Ratthaphol Kraiklang, Anucha Puapairoj, Chaisiri Wongkham, Gregory J. Riggins, Sopit Wongkham. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma. Annals of Hepatology 2016; 15(1): 71 doi: 10.5604/16652681.1184223
|
| 26 |
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Inês Pombeiro, Catherine Leyh, Fabian Benz, Mihael Vucur, Thomas Longerich, Alexander Koch, Till Braunschweig, Tom F. Ulmer, Christoph Heidenhain, Frank Tacke, Marcel Binnebösel, Maximilian Schmeding, Christian Trautwein, Ulf P. Neumann, Tom Luedde. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma. Journal of Hepatology 2017; 67(4): 749 doi: 10.1016/j.jhep.2017.06.020
|
| 27 |
Laurent Sulpice, Michel Rayar, Mireille Desille, Bruno Turlin, Alain Fautrel, Eveline Boucher, Francisco Llamas-Gutierrez, Bernard Meunier, Karim Boudjema, Bruno Clément, Cédric Coulouarn. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. Hepatology 2013; 58(6): 1992 doi: 10.1002/hep.26577
|